187 results
Page 2 of 10
8-K
EX-10.2
06aiw1mn
20 May 22
Tenax Therapeutics Announces Certain Securities and Nasdaq Disclosures
4:30pm
8-K
EX-10.1
zi2nj35
28 Jan 22
Entry into a Material Definitive Agreement
4:16pm
8-K
EX-10.1
jzu5y2u1kob2 627
8 Jul 21
Tenax Therapeutics Announces CEO Transition and Certain Securities and Nasdaq Disclosures
8:31am
8-K
EX-10.4
ka8dxf jk7
8 Jul 21
Tenax Therapeutics Announces CEO Transition and Certain Securities and Nasdaq Disclosures
8:31am
8-K
EX-10.2
bz59cz2xr
8 Jul 21
Tenax Therapeutics Announces CEO Transition and Certain Securities and Nasdaq Disclosures
8:31am
8-K
EX-10.3
xxhzn65cnycuepl7 f7
8 Jul 21
Tenax Therapeutics Announces CEO Transition and Certain Securities and Nasdaq Disclosures
8:31am
8-K
EX-10.5
1tibgmaheebwpbkx
8 Jul 21
Tenax Therapeutics Announces CEO Transition and Certain Securities and Nasdaq Disclosures
8:31am
8-K
EX-10.1
dsa9pykrx4
19 Jan 21
Tenax Therapeutics, Inc. Announces Transformative Acquisition of PH Precision Med
8:30am
8-K
EX-10.1
185ezexhh8 e2
15 Oct 20
Tenax Therapeutics Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation
8:46am
8-K
EX-10.2
c55o psv1cp7cd
8 Jul 20
Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings
9:00am
8-K
EX-10.1
u3y4m0x02p7si9sztva1
8 Jul 20
Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings
9:00am
8-K
EX-10.3
xelq9o18kvhg
8 Jul 20
Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings
9:00am